Tirzepatide represents a groundbreaking pharmaceutical agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://kaitlynmwib982165.vblogetin.com/46620277/tirzepatide-a-new-frontier-in-diabetes-treatment